NUMA1 and urinary bladder cancer: Thus, while useful tools for managing bladder cancer include BTA STAT, BTA TRAK, and NMP22 alone they might have limitations such as sensitivity or specificity and they can produce false positive results; therefore other diagnostic methods such as cystoscopy must be used in conjunction with them (54, 56).